Hesperos and UCF Create Human iPSC Myelination Model for Peripheral Nervous System Research
Hesperos, a leader in human biology recreation with its Human-on-a-Chip® platform, has made a significant advancement by developing a human induced pluripotent stem cell (iPSC)-derived model of peripheral myelination. This research, published in ACS Biomaterials, was conducted in collaboration with…
Precision BioSciences Shares Preclinical Data on ARCUS Gene Editing at ESGCT 31st Congress
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company using its proprietary ARCUS® platform for advanced in vivo gene editing therapies, announced a poster presentation at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress, taking…
PharmaJet Study: Improved Polio Immunization with Tropis® ID Delivery
PharmaJet®, a company focused on enhancing injectable performance with its needle-free technology, has announced the results of an implementation study in Nigeria. This study evaluated the impact of administering the intradermal fractional inactivated poliovirus vaccine (fIPV) using the Tropis® ID…
Prisma Health and Upfront Healthcare Activate Nearly One Million Patients, Says Leading Journal
Upfront Healthcare’s collaboration with Prisma Health, which has successfully engaged nearly one million patients, is featured in the latest issue of The Healthcare Administration Leadership & Management (HALM) Journal. Published by the American Association for Physician Leadership (AAPL), this journal…
Two-Year Data Confirm Efficacy and Safety of Tibial NeuroModulation for Urgency Urinary Incontinence
BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the creator of the Revi® System, has announced the presentation of new two-year data from its OASIS pivotal study. These findings were shared at the American Urogynecologic Society (AUGS)…
Simulations Plus Releases Q4 and Fiscal 2024 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a top provider of biosimulation and performance solutions for the biopharma industry, has announced its financial results for the fourth quarter and fiscal year 2024, ending August 31, 2024. Fourth Quarter 2024 Financial Highlights (vs.…
Rubedo Life Sciences Expands into Europe Ahead of First Clinical Trial
Rubedo Life Sciences, a biopharmaceutical company dedicated to developing advanced therapies targeting senescent cells linked to age-related diseases, has announced the opening of its European headquarters and clinical operations in Milan. This expansion precedes the company’s inaugural in-human Phase 1…
CareMonitor Selects 8×8 CPaaS for Key Patient Interactions
8×8, Inc. (NASDAQ: EGHT), a prominent provider of business communications, customer experience (CX), and CPaaS platforms, has announced that CareMonitor has successfully implemented 8×8 CPaaS to enhance critical patient interactions. The integration of 8×8 Jitsi as a Service (JaaS) and…
Modivcare and Michigan Center for Rural Health Launch Remote Patient Monitoring in Rural Hospitals
Modivcare Inc. (Nasdaq: MODV), a technology-enabled healthcare services company focused on improving health outcomes through integrated supportive care solutions, has successfully completed an 18-month Remote Patient Monitoring (RPM) pilot program. This initiative, conducted in collaboration with the Michigan Center for…
CDC’s ACIP Recommends Merck’s CAPVAXIVE™ Pneumococcal Vaccine for Adults 50+
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) has voted to update the pneumococcal vaccination guidelines for adults. The committee recommends CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)…
AMRA® Profiler 4 Pilot Study Shows Feasible Muscle Composition Assessment in Liver Transplant Candidates
A recent study published in the Annals of Hepatology investigated the feasibility of using the AMRA® MAsS Scan, powered by the FDA-cleared AMRA® Profiler 4 device, to assess muscle composition in patients with end-stage liver disease (ESLD). This research is…
Align Technology Launches Invisalign Smile Architect™ for Enhanced Ortho Restorative Options
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for restorative dentistry, has announced the launch of the latest version of its Invisalign Smile Architect…